Global Burden of Disease Study 2021 (GBD 2021) Bacterial Antimicrobial Resistance Burden Estimates 1990-2021 and Forecasts 2022-2050
General Info
Provider
Institute for Health Metrics and Evaluation (IHME)
Coverage type
Global
Time period covered
January, 1990 - December, 2050
Data type
Estimate
Summary
The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.
This dataset provides annual estimates for age-specific fertility rate (ASFR), total fertility fate (TFR) and live births for 1950-2100. Data sources used to produce the estimates came from 8709 country-years of vital and sample registrations, 1455 surveys and censuses, and 150 other sources.
Keywords
Antibiotics, Bacterial skin diseases, Carbapenem, Cardiovascular and circulatory diseases, Chlamydia, Chloramphenicol, DALYs, Diarrhea, Digestive diseases, Drug resistance, E. coli, Endocarditis, Fluoroquinolone, GAS infection, GBS infection, Gonococcal infections, Haemophilus influenzae infection, Infectious diseases, Invasive nontyphoidal salmonella, Lower respiratory infections, MRSA infection, Meningitis, Meningococcal infection, Mortality, Musculoskeletal diseases, Pathogens, Penicillin, Peritonitis, Salmonella infections, Shigellosis, Streptococcus pneumoniae infection, Tuberculosis, Typhoid and paratyphoid fevers, Urinary tract infections, YLDs, YLLs
Citation
Publication year
2024
Suggested citation
Institute for Health Metrics and Evaluation (IHME), University of Oxford. Global Burden of Disease Study 2021 (GBD 2021) Bacterial Antimicrobial Resistance Burden Estimates 1990-2021 and Forecasts 2022-2050. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2024.
Files (2)
Public files
| File | Size |
|---|---|
 Data Release Information Sheet | 88.81 KB |
 Codebook [CSV] | 2.77 KB |